Table: Taiko Pharmaceutical -2022 group results

Taiko Pharmaceutical

10/02/2023 06:30

Feb 10 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended       Year to       NEXT   
               Dec 31, 2022     Dec 31, 2021   Dec 31, 2023     YEAR     
                  LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS        FORECAST    H1 FORECAST 
  Sales            5.04            11.30           7.90                  
                                                (+56.7 pct)              
  Operating     loss 3.08        loss 4.95        532 mln                
  Recurring     loss 3.35        loss 6.13        60 mln                 
  Net
  Net           loss 4.90        loss 9.59        50 mln                 
  EPS        loss 112.26 yen  loss 220.52 yen    1.15 yen                
  Ann Div          NIL              NIL                                  
  -Q2 Div          NIL              NIL                                  
  -Q4 Div          NIL              NIL                                  
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T